1
|
Dorn G, Gmeiner C, de Vries T, Dedic E, Novakovic M, Damberger FF, Maris C, Finol E, Sarnowski CP, Kohlbrecher J, Welsh TJ, Bolisetty S, Mezzenga R, Aebersold R, Leitner A, Yulikov M, Jeschke G, Allain FHT. Integrative solution structure of PTBP1-IRES complex reveals strong compaction and ordering with residual conformational flexibility. Nat Commun 2023; 14:6429. [PMID: 37833274 PMCID: PMC10576089 DOI: 10.1038/s41467-023-42012-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2022] [Accepted: 09/27/2023] [Indexed: 10/15/2023] Open
Abstract
RNA-binding proteins (RBPs) are crucial regulators of gene expression, often composed of defined domains interspersed with flexible, intrinsically disordered regions. Determining the structure of ribonucleoprotein (RNP) complexes involving such RBPs necessitates integrative structural modeling due to their lack of a single stable state. In this study, we integrate magnetic resonance, mass spectrometry, and small-angle scattering data to determine the solution structure of the polypyrimidine-tract binding protein 1 (PTBP1/hnRNP I) bound to an RNA fragment from the internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV). This binding, essential for enhancing the translation of viral RNA, leads to a complex structure that demonstrates RNA and protein compaction, while maintaining pronounced conformational flexibility. Acting as an RNA chaperone, PTBP1 orchestrates the IRES RNA into a few distinct conformations, exposing the RNA stems outward. This conformational diversity is likely common among RNP structures and functionally important. Our approach enables atomic-level characterization of heterogeneous RNP structures.
Collapse
Affiliation(s)
- Georg Dorn
- Institute of Biochemistry, Department of Biology, ETH Zürich, Zürich, Switzerland
| | - Christoph Gmeiner
- Laboratory of Physical Chemistry, Department of Chemistry and Applied Biosciences, ETH Zürich, Zürich, Switzerland
| | - Tebbe de Vries
- Institute of Biochemistry, Department of Biology, ETH Zürich, Zürich, Switzerland
| | - Emil Dedic
- Institute of Biochemistry, Department of Biology, ETH Zürich, Zürich, Switzerland
| | - Mihajlo Novakovic
- Institute of Biochemistry, Department of Biology, ETH Zürich, Zürich, Switzerland
| | - Fred F Damberger
- Institute of Biochemistry, Department of Biology, ETH Zürich, Zürich, Switzerland
| | - Christophe Maris
- Institute of Biochemistry, Department of Biology, ETH Zürich, Zürich, Switzerland
| | - Esteban Finol
- Institute of Biochemistry, Department of Biology, ETH Zürich, Zürich, Switzerland
| | - Chris P Sarnowski
- Institute of Molecular Systems Biology, Department of Biology, ETH Zürich, Zürich, Switzerland
| | - Joachim Kohlbrecher
- Laboratory for Neutron Scattering and Imaging, Paul Scherrer Institut, Villigen, Switzerland
| | - Timothy J Welsh
- Laboratory of Physical Chemistry, Department of Chemistry and Applied Biosciences, ETH Zürich, Zürich, Switzerland
| | - Sreenath Bolisetty
- Laboratory of Food & Soft Materials, Institute of Food, Nutrition and Health, Department for Health Sciences and Technology, ETH Zürich, Zürich, Switzerland
| | - Raffaele Mezzenga
- Laboratory of Food & Soft Materials, Institute of Food, Nutrition and Health, Department for Health Sciences and Technology, ETH Zürich, Zürich, Switzerland
| | - Ruedi Aebersold
- Institute of Molecular Systems Biology, Department of Biology, ETH Zürich, Zürich, Switzerland
| | - Alexander Leitner
- Institute of Molecular Systems Biology, Department of Biology, ETH Zürich, Zürich, Switzerland
| | - Maxim Yulikov
- Laboratory of Physical Chemistry, Department of Chemistry and Applied Biosciences, ETH Zürich, Zürich, Switzerland.
| | - Gunnar Jeschke
- Laboratory of Physical Chemistry, Department of Chemistry and Applied Biosciences, ETH Zürich, Zürich, Switzerland.
| | - Frédéric H-T Allain
- Institute of Biochemistry, Department of Biology, ETH Zürich, Zürich, Switzerland.
| |
Collapse
|
2
|
Harvey C, Klassa S, Finol E, Hall J, Hill AC. Chimeric Flaviviral RNA-siRNA Molecules Resist Degradation by The Exoribonuclease Xrn1 and Trigger Gene Silencing in Mammalian Cells. Chembiochem 2021; 22:3099-3106. [PMID: 34431199 PMCID: PMC8596575 DOI: 10.1002/cbic.202100434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2021] [Indexed: 11/11/2022]
Abstract
RNA is an emerging platform for drug delivery, but the susceptibility of RNA to nuclease degradation remains a major barrier to its implementation in vivo. Here, we engineered flaviviral Xrn1-resistant RNA (xrRNA) motifs to host small interfering RNA (siRNA) duplexes. The xrRNA-siRNA molecules self-assemble in vitro, resist degradation by the conserved eukaryotic 5' to 3' exoribonuclease Xrn1, and trigger gene silencing in 293T cells. The resistance of the molecules to Xrn1 does not translate to stability in blood serum. Nevertheless, our results demonstrate that flavivirus-derived xrRNA motifs can confer Xrn1 resistance on a model therapeutic payload and set the stage for further investigations into using the motifs as building blocks in RNA nanotechnology.
Collapse
Affiliation(s)
- Cressida Harvey
- Department of BiologyETH ZürichWolfgang-Pauli-Strasse 278093ZürichSwitzerland
| | - Sven Klassa
- Department of Chemistry and Applied BiosciencesInstitute of Pharmaceutical SciencesETH ZürichVladimir-Prelog-Weg 1-5/108093ZürichSwitzerland
| | - Esteban Finol
- Department of BiologyETH ZürichWolfgang-Pauli-Strasse 278093ZürichSwitzerland
| | - Jonathan Hall
- Department of Chemistry and Applied BiosciencesInstitute of Pharmaceutical SciencesETH ZürichVladimir-Prelog-Weg 1-5/108093ZürichSwitzerland
| | - Alyssa C. Hill
- Department of Chemistry and Applied BiosciencesInstitute of Pharmaceutical SciencesETH ZürichVladimir-Prelog-Weg 1-5/108093ZürichSwitzerland
| |
Collapse
|
3
|
Boyles SM, Mavian CN, Finol E, Ukhanova M, Stephenson CJ, Hamerlinck G, Kang S, Baumgartner C, Geesey M, Stinton I, Williams K, Mathias DK, Prosperi M, Mai V, Salemi M, Buckner EA, Lednicky JA, Rivers AR, Dinglasan RR. Under-the-Radar Dengue Virus Infections in Natural Populations of Aedes aegypti Mosquitoes. mSphere 2020; 5:e00316-20. [PMID: 32350095 PMCID: PMC7193045 DOI: 10.1128/msphere.00316-20] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Accepted: 04/12/2020] [Indexed: 12/30/2022] Open
Abstract
The incidence of locally acquired dengue infections increased during the last decade in the United States, compelling a sustained research effort concerning the dengue mosquito vector, Aedes aegypti, and its microbiome, which has been shown to influence virus transmission success. We examined the "metavirome" of four populations of Aedes aegypti mosquitoes collected in 2016 to 2017 in Manatee County, FL. Unexpectedly, we discovered that dengue virus serotype 4 (DENV4) was circulating in these mosquito populations, representing the first documented case of such a phenomenon in the absence of a local DENV4 human case in this county over a 2-year period. We confirmed that all of the mosquito populations carried the same DENV4 strain, assembled its full genome, validated infection orthogonally by reverse transcriptase PCR, traced the virus origin, estimated the time period of its introduction to the Caribbean region, and explored the viral genetic signatures and mosquito-specific virome associations that potentially mediated DENV4 persistence in mosquitoes. We discuss the significance of prolonged maintenance of the DENV4 infections in A. aegypti that occurred in the absence of a DENV4 human index case in Manatee County with respect to the inability of current surveillance paradigms to detect mosquito vector infections prior to a potential local outbreak.IMPORTANCE Since 1999, dengue outbreaks in the continental United States involving local transmission have occurred only episodically and only in Florida and Texas. In Florida, these episodes appear to be coincident with increased introductions of dengue virus into the region through human travel and migration from countries where the disease is endemic. To date, the U.S. public health response to dengue outbreaks has been largely reactive, and implementation of comprehensive arbovirus surveillance in advance of predictable transmission seasons, which would enable proactive preventative efforts, remains unsupported. The significance of our finding is that it is the first documented report of DENV4 transmission to and maintenance within a local mosquito vector population in the continental United States in the absence of a human case during two consecutive years. Our data suggest that molecular surveillance of mosquito populations in high-risk, high-tourism areas of the United States may enable proactive, targeted vector control before potential arbovirus outbreaks.
Collapse
Affiliation(s)
- Sean M Boyles
- Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA
- Department of Infectious Diseases & Immunology, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA
- CDC Southeastern Center of Excellence in Vector Borne Diseases, Gainesville, Florida, USA
| | - Carla N Mavian
- Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA
- Department of Pathology, College of Medicine, University of Florida, Gainesville, Florida, USA
| | - Esteban Finol
- Institute for Molecular Biology and Biophysics, ETH Zurich, Zurich, Switzerland
| | - Maria Ukhanova
- Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA
- Department of Epidemiology, College of Public Health and Health Professions & College of Medicine, University of Florida, Gainesville, Florida, USA
| | - Caroline J Stephenson
- Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA
- Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, USA
- CDC Southeastern Center of Excellence in Vector Borne Diseases, Gainesville, Florida, USA
| | - Gabriela Hamerlinck
- Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA
- Department of Geography, College of Liberal Arts & Sciences, University of Florida, Gainesville, Florida, USA
- CDC Southeastern Center of Excellence in Vector Borne Diseases, Gainesville, Florida, USA
| | - Seokyoung Kang
- Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA
- Department of Infectious Diseases & Immunology, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA
- CDC Southeastern Center of Excellence in Vector Borne Diseases, Gainesville, Florida, USA
| | | | - Mary Geesey
- Manatee County Mosquito Control District, Palmetto, Florida, USA
| | - Israel Stinton
- Manatee County Mosquito Control District, Palmetto, Florida, USA
| | - Katie Williams
- Manatee County Mosquito Control District, Palmetto, Florida, USA
| | - Derrick K Mathias
- CDC Southeastern Center of Excellence in Vector Borne Diseases, Gainesville, Florida, USA
- Florida Medical Entomology Laboratory, Institute of Food and Agricultural Sciences, University of Florida, Vero Beach, Florida, USA
| | - Mattia Prosperi
- Department of Epidemiology, College of Public Health and Health Professions & College of Medicine, University of Florida, Gainesville, Florida, USA
| | - Volker Mai
- Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA
- Department of Epidemiology, College of Public Health and Health Professions & College of Medicine, University of Florida, Gainesville, Florida, USA
| | - Marco Salemi
- Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA
- Department of Pathology, College of Medicine, University of Florida, Gainesville, Florida, USA
| | - Eva A Buckner
- CDC Southeastern Center of Excellence in Vector Borne Diseases, Gainesville, Florida, USA
- Manatee County Mosquito Control District, Palmetto, Florida, USA
- Florida Medical Entomology Laboratory, Institute of Food and Agricultural Sciences, University of Florida, Vero Beach, Florida, USA
| | - John A Lednicky
- Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA
- Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, USA
- CDC Southeastern Center of Excellence in Vector Borne Diseases, Gainesville, Florida, USA
| | - Adam R Rivers
- CDC Southeastern Center of Excellence in Vector Borne Diseases, Gainesville, Florida, USA
- Genomics and Bioinformatics Research Unit, Agricultural Research Service, United States Department of Agriculture, Gainesville, Florida, USA
| | - Rhoel R Dinglasan
- Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA
- Department of Infectious Diseases & Immunology, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA
- CDC Southeastern Center of Excellence in Vector Borne Diseases, Gainesville, Florida, USA
| |
Collapse
|
4
|
Finol E, Ooi EE. Evolution of Subgenomic RNA Shapes Dengue Virus Adaptation and Epidemiological Fitness. iScience 2019; 16:94-105. [PMID: 31154208 PMCID: PMC6545344 DOI: 10.1016/j.isci.2019.05.019] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2018] [Revised: 02/02/2019] [Accepted: 05/13/2019] [Indexed: 01/07/2023] Open
Abstract
Changes in dengue virus (DENV) genome affect viral fitness both clinically and epidemiologically. Even in the 3′ untranslated region (3′ UTR), mutations could affect subgenomic flaviviral RNA (sfRNA) production and its affinity for host proteins, which are necessary for successful viral replication. Indeed, we recently showed that mutations in DENV2 3′ UTR of epidemic strains increased sfRNA ability to bind host proteins and reduce interferon expression. However, whether 3′ UTR differences shape the overall DENV evolution remains incompletely understood. Herein, we combined RNA phylogeny with phylogenetics to gain insights on sfRNA evolution. We found that sfRNA structures are under purifying selection and highly conserved despite sequence divergence. Only the second flaviviral nuclease-resistant RNA (fNR2) structure of DENV2 sfRNA has undergone strong positive selection. Epidemiological reports suggest that substitutions in fNR2 may drive DENV2 epidemiological fitness, possibly through sfRNA-protein interactions. Collectively, our findings indicate that 3′ UTRs are important determinants of DENV fitness in human-mosquito cycles. Dengue viruses (DENVs) preserve RNA elements in their 3′ untranslated region (UTR). Quantification of natural selection revealed positive selection on DENV2 sfRNA Flaviviral nuclease-resistant RNAs (fNR) in the 3′ UTRs contribute to DENV speciation A highly evolving fNR structure appears to increase DENV2 epidemiological fitness
Collapse
Affiliation(s)
- Esteban Finol
- Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore; Swiss Tropical and Public Health Institute, University of Basel, Basel 4051, Switzerland; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
| | - Eng Eong Ooi
- Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore; Saw Swee Hock School of Public Health, National University of Singapore, Singapore 117549, Singapore.
| |
Collapse
|
5
|
Manokaran G, Finol E, Wang C, Gunaratne J, Bahl J, Ong EZ, Tan HC, Sessions OM, Ward AM, Gubler DJ, Harris E, Garcia-Blanco MA, Ooi EE. Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness. Science 2015; 350:217-21. [PMID: 26138103 PMCID: PMC4824004 DOI: 10.1126/science.aab3369] [Citation(s) in RCA: 282] [Impact Index Per Article: 31.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2015] [Accepted: 06/22/2015] [Indexed: 11/02/2022]
Abstract
The global spread of dengue virus (DENV) infections has increased viral genetic diversity, some of which appears associated with greater epidemic potential. The mechanisms governing viral fitness in epidemiological settings, however, remain poorly defined. We identified a determinant of fitness in a foreign dominant (PR-2B) DENV serotype 2 (DENV-2) clade, which emerged during the 1994 epidemic in Puerto Rico and replaced an endemic (PR-1) DENV-2 clade. The PR-2B DENV-2 produced increased levels of subgenomic flavivirus RNA (sfRNA) relative to genomic RNA during replication. PR-2B sfRNA showed sequence-dependent binding to and prevention of tripartite motif 25 (TRIM25) deubiquitylation, which is critical for sustained and amplified retinoic acid-inducible gene 1 (RIG-I)-induced type I interferon expression. Our findings demonstrate a distinctive viral RNA-host protein interaction to evade the innate immune response for increased epidemiological fitness.
Collapse
Affiliation(s)
- Gayathri Manokaran
- Program in Emerging Infectious Diseases, Duke-National University of Singapore Graduate Medical School, Singapore. Defence Medical and Environmental Research Institute, DSO National Laboratories, Singapore. Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | - Esteban Finol
- Program in Emerging Infectious Diseases, Duke-National University of Singapore Graduate Medical School, Singapore. Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Swiss Tropical and Public Health Institute, Universität Basel, Switzerland
| | - Chunling Wang
- Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA, USA
| | - Jayantha Gunaratne
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Institute of Molecular and Cell Biology, Singapore
| | - Justin Bahl
- Center for Infectious Diseases, The University of Texas School of Public Health, Houston, TX, USA
| | - Eugenia Z Ong
- Program in Emerging Infectious Diseases, Duke-National University of Singapore Graduate Medical School, Singapore
| | - Hwee Cheng Tan
- Program in Emerging Infectious Diseases, Duke-National University of Singapore Graduate Medical School, Singapore
| | - October M Sessions
- Program in Emerging Infectious Diseases, Duke-National University of Singapore Graduate Medical School, Singapore
| | - Alex M Ward
- Program in Emerging Infectious Diseases, Duke-National University of Singapore Graduate Medical School, Singapore
| | - Duane J Gubler
- Program in Emerging Infectious Diseases, Duke-National University of Singapore Graduate Medical School, Singapore
| | - Eva Harris
- Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA, USA
| | - Mariano A Garcia-Blanco
- Program in Emerging Infectious Diseases, Duke-National University of Singapore Graduate Medical School, Singapore. Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX, USA. Department of Molecular Genetics and Microbiology and Center for RNA Biology, Duke University, Durham, NC, USA
| | - Eng Eong Ooi
- Program in Emerging Infectious Diseases, Duke-National University of Singapore Graduate Medical School, Singapore. Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Saw Swee Hock School of Public Health, National University of Singapore, Singapore. Singapore-Massachusetts Institute of Technology Alliance in Research and Technology Infectious Disease Interdisciplinary Research Group, Singapore.
| |
Collapse
|
6
|
Rincón J, Correia D, Arcaya JL, Finol E, Fernández A, Pérez M, Yaguas K, Talavera E, Chávez M, Summer R, Romero F. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension. Life Sci 2015; 124:81-90. [PMID: 25623850 DOI: 10.1016/j.lfs.2015.01.005] [Citation(s) in RCA: 65] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2014] [Revised: 01/07/2015] [Accepted: 01/08/2015] [Indexed: 02/07/2023]
Abstract
AIMS Activation of the renin-angiotensin system (RAS), renal oxidative stress and inflammation are constantly present in experimental hypertension. Nitric oxide (NO) inhibition with N(w)-nitro-L-arginine methyl ester (L-NAME) has previously been reported to produce hypertension, increased expression of Angiotensin II (Ang II) and renal dysfunction. The use of Losartan, an Ang II type 1 receptor (AT1R) antagonist has proven to be effective reducing hypertension and renal damage; however, the mechanism by which AT1R blockade reduced kidney injury and normalizes blood pressure in this experimental model is still complete unknown. The current study was designed to test the hypothesis that AT1R activation promotes renal NAD(P)H oxidase up-regulation, oxidative stress and cytokine production during L-NAME induced-hypertension. MAIN METHODS Male Sprague-Dawley rats were distributed in three groups: L-NAME, receiving 70 mg/100ml of L-NAME, L-NAME+Los, receiving 70 mg/100ml of L-NAME and 40 mg/kg/day of Losartan; and Controls, receiving water instead of L-NAME or L-NAME and Losartan. KEY FINDINGS After two weeks, L-NAME induced high blood pressure, renal overexpression of AT1R, NAD(P)H oxidase sub-units gp91, p22 and p47, increased levels of oxidative stress, interleukin-6 (IL-6) and interleukin-17 (IL-17). Also, we found increased renal accumulation of lymphocytes and macrophages. Losartan treatment abolished the renal expression of gp91, p22, p47, oxidative stress and reduced NF-κB activation and IL-6 expression. SIGNIFICANCE These findings indicate that NO induced-hypertension is associated with up-regulation of NADPH oxidase, oxidative stress production and overexpression of key inflammatory mediators. These events are associated with up-regulation of AT1R, as evidenced by their reversal with AT1R blocker treatment.
Collapse
Affiliation(s)
- J Rincón
- Centro de Medicina y Cirugía Experimental, Universidad del Zulia, Venezuela
| | - D Correia
- Centro de Investigaciones Biomédicas, IVIC-Zulia, Venezuela
| | - J L Arcaya
- Instituto de Investigaciones Clínicas "Dr. Américo Negrette", Universidad del Zulia, Venezuela
| | - E Finol
- Philosophisch-Naturwissenschaftliche Fakultät, Universität Basel, Yong Loo Lin School of Medicine, National University of, Singapore
| | - A Fernández
- Instituto de Investigaciones Clínicas "Dr. Américo Negrette", Universidad del Zulia, Venezuela
| | - M Pérez
- Centro de Investigaciones Biomédicas, IVIC-Zulia, Venezuela
| | - K Yaguas
- Centro de Investigaciones Biomédicas, IVIC-Zulia, Venezuela
| | - E Talavera
- Centro de Investigaciones Biomédicas, IVIC-Zulia, Venezuela
| | - M Chávez
- Escuela de Medicina, Universidad del Zulia, Venezuela
| | - R Summer
- Center for Translational Medicine and Jane and Leonard Korman Lung Center, Thomas Jefferson University, Philadelphia, USA
| | - F Romero
- Center for Translational Medicine and Jane and Leonard Korman Lung Center, Thomas Jefferson University, Philadelphia, USA.
| |
Collapse
|
7
|
Lanaspa MA, Ishimoto T, Cicerchi C, Tamura Y, Roncal-Jimenez CA, Chen W, Tanabe K, Andres-Hernando A, Orlicky DJ, Finol E, Inaba S, Li N, Rivard CJ, Kosugi T, Sanchez-Lozada LG, Petrash JM, Sautin YY, Ejaz AA, Kitagawa W, Garcia GE, Bonthron DT, Asipu A, Diggle CP, Rodriguez-Iturbe B, Nakagawa T, Johnson RJ. Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy. J Am Soc Nephrol 2014; 25:2526-38. [PMID: 24876114 DOI: 10.1681/asn.2013080901] [Citation(s) in RCA: 114] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
Diabetes is associated with activation of the polyol pathway, in which glucose is converted to sorbitol by aldose reductase. Previous studies focused on the role of sorbitol in mediating diabetic complications. However, in the proximal tubule, sorbitol can be converted to fructose, which is then metabolized largely by fructokinase, also known as ketohexokinase, leading to ATP depletion, proinflammatory cytokine expression, and oxidative stress. We and others recently identified a potential deleterious role of dietary fructose in the generation of tubulointerstitial injury and the acceleration of CKD. In this study, we investigated the potential role of endogenous fructose production, as opposed to dietary fructose, and its metabolism through fructokinase in the development of diabetic nephropathy. Wild-type mice with streptozotocin-induced diabetes developed proteinuria, reduced GFR, and renal glomerular and proximal tubular injury. Increased renal expression of aldose reductase; elevated levels of renal sorbitol, fructose, and uric acid; and low levels of ATP confirmed activation of the fructokinase pathway. Furthermore, renal expression of inflammatory cytokines with macrophage infiltration was prominent. In contrast, diabetic fructokinase-deficient mice demonstrated significantly less proteinuria, renal dysfunction, renal injury, and inflammation. These studies identify fructokinase as a novel mediator of diabetic nephropathy and document a novel role for endogenous fructose production, or fructoneogenesis, in driving renal disease.
Collapse
Affiliation(s)
- Miguel A Lanaspa
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado;
| | - Takuji Ishimoto
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado
| | - Christina Cicerchi
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado
| | - Yoshifuru Tamura
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado
| | - Carlos A Roncal-Jimenez
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado
| | - Wei Chen
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado
| | - Katsuyuki Tanabe
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado
| | - Ana Andres-Hernando
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado
| | - David J Orlicky
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado
| | - Esteban Finol
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado; Venezuelan Scientific Research Institute and University Hospital of Zulia, Maracaibo, Venezuela
| | - Shinichiro Inaba
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado
| | - Nanxing Li
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado
| | - Christopher J Rivard
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado
| | - Tomoki Kosugi
- Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Laura G Sanchez-Lozada
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado; Laboratory of Renal Physiopathology and Department of Nephrology, INC Ignacio Chavez, Mexico City, Mexico
| | - J Mark Petrash
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado
| | | | - A Ahsan Ejaz
- Division of Nephrology, Hypertension, and Transplantation, University of Florida, Gainesville, Florida
| | - Wataru Kitagawa
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado
| | - Gabriela E Garcia
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado
| | - David T Bonthron
- Leeds Institute of Biomedical & Clinical Sciences, University of Leeds, Leeds, United Kingdom; and
| | - Aruna Asipu
- Leeds Institute of Biomedical & Clinical Sciences, University of Leeds, Leeds, United Kingdom; and
| | - Christine P Diggle
- Leeds Institute of Biomedical & Clinical Sciences, University of Leeds, Leeds, United Kingdom; and
| | | | - Takahiko Nakagawa
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado; TMK Project, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - Richard J Johnson
- The Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Denver, Colorado
| |
Collapse
|
8
|
Gounis M, Nogueira R, Mehra M, Finol E, Yang Y, Jahrmarkt S, Migliuolo M, Wakhloo A. O-006 Pharmaco-mechanical clot disruption using a balloon infusion wire in an acute rabbit common carotid artery thromboembolic occlusion model. J Neurointerv Surg 2011. [DOI: 10.1136/neurintsurg-2011-010097.6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|